** Shares of medical device maker Tandem Diabetes Care TNDM.O rise 3.8% to $21.50 in extended trading
** Company says it entered into a settlement agreement with Roche ROG.S to resolve patent disputes related to TNDM's insulin pump, t:slim X2
** TNDM will pay Roche $36 million over a five-year period, with an initial payment of $8 million as part of the settlement
** Up to last close, TNDM down 42.5% YTD
(Reporting by Christy Santhosh)
((Christy.Santhosh@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.